Biocartis Group NV (BIOGF)

USD 0.66

(-85.33%)

EBITDA Summary of Biocartis Group NV

  • Biocartis Group NV's latest annual EBITDA in 2022 was -43.95 Million EUR , up 16.37% from previous year.
  • Biocartis Group NV's latest quarterly EBITDA in 2023 Q2 was -7786.00 EUR , down 0.0% from previous quarter.
  • Biocartis Group NV reported an annual EBITDA of -52.55 Million EUR in 2021, down -22.11% from previous year.
  • Biocartis Group NV reported an annual EBITDA of -43.23 Million EUR in 2020, up 9.22% from previous year.
  • Biocartis Group NV reported a quarterly EBITDA of -7786.00 EUR for 2023 Q1, up 2.98% from previous quarter.
  • Biocartis Group NV reported a quarterly EBITDA of -8025.00 EUR for 2022 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Biocartis Group NV (2022 - 2019)

Historical Annual EBITDA of Biocartis Group NV (2022 - 2019)

Year EBITDA EBITDA Growth
2022 -43.95 Million EUR 16.37%
2021 -52.55 Million EUR -22.11%
2020 -43.23 Million EUR 9.22%
2019 -47.34 Million EUR 0.0%

Peer EBITDA Comparison of Biocartis Group NV

Name EBITDA EBITDA Difference
American Bio Medica Corporation -1.16 Million USD -3679.278%
Arrayit Corporation -3.07 Million USD -1328.207%
Atlantic International Corp. -5.38 Million USD -715.521%
Biocept, Inc. -30.24 Million USD -45.342%
Bioqual, Inc. 3.03 Million USD 1549.522%
CardioGenics Holdings Inc -757.37 Thousand USD -5703.334%
DermTech, Inc. -97.89 Million USD 55.101%
Global WholeHealth Partners Corporation - USD Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 2.91 Billion USD 101.508%
HTG Molecular Diagnostics, Inc. -20.24 Million USD -117.133%
iMD Companies, Inc. -154.65 Thousand USD -28319.297%
IDenta Corp. 71.58 Thousand USD 61498.019%
Interpace Biosciences, Inc. 3.83 Million USD 1245.504%
Integrative Health Technologies, Inc. 38.69 Thousand USD 113702.998%
InVitro International 6680.00 USD 658079.042%
Lumos Diagnostics Holdings Limited -5.43 Million USD -708.554%
Many Bright Ideas Technologies Inc. -12.13 Thousand USD -362130.097%
Medical Imaging Corp. -896.74 Thousand USD -4801.41%
NovelStem International Corp. -3.78 Million USD -1060.997%
Optigenex Inc. -1.18 Million USD -3603.726%
PharmChem, Inc. 1.05 Million USD 4270.866%
Proteome Sciences plc -1.13 Million USD -3765.699%
Response Genetics, Inc -19.66 Million USD -123.497%
Rennova Health, Inc. -234.81 Thousand USD -18618.14%
RushNet, Inc. -614.85 Thousand USD -7048.55%
ScreenPro Security Inc. -3.43 Million USD -1179.605%
Stella Diagnostics Inc. -5.7 Million USD -670.101%
StageZero Life Sciences Ltd. -10.27 Million USD -327.969%
Todos Medical Ltd. -9.39 Million USD -367.884%